- Home
- NPT vs ZTEK Comparison
NPT vs ZTEK Comparison
Compare NPT & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPT | ZTEK |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 51.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NPT | ZTEK |
|---|---|---|
| Price | $2.72 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 131.9K | ★ 262.5K |
| Earning Date | 05-23-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.14 | $0.37 |
| 52 Week High | $22.38 | $1.24 |
Technical Indicators
Market Signals| Indicator | NPT | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 46.13 |
| Support Level | $2.20 | $0.38 |
| Resistance Level | $3.21 | $0.56 |
| Average True Range (ATR) | 0.29 | 0.06 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 29.57 | 43.51 |
Price Performance
Historical ComparisonAbout NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.